Comments
Loading...

Inovio Pharmaceuticals

INONASDAQ
Logo brought to you by Benzinga Data
$6.69
-0.08-1.18%
At Close: -
$6.86
0.172.47%
After Hours: 6:36 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$40.00
Lowest Price Target1
$1.00
Consensus Price Target1
$17.00

Inovio Pharmaceuticals (NASDAQ:INO) Stock, Analyst Ratings, Price Targets, Forecasts

Inovio Pharmaceuticals Inc has a consensus price target of $17 based on the ratings of 8 analysts. The high is $40 issued by Oppenheimer on March 8, 2024. The low is $1 issued by JMP Securities on January 4, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, RBC Capital, and HC Wainwright & Co. on August 12, 2024, August 9, 2024, and July 15, 2024, respectively. With an average price target of $18.67 between Oppenheimer, RBC Capital, and HC Wainwright & Co., there's an implied 172.30% upside for Inovio Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
RBC Capital
HC Wainwright & Co.
Stephens & Co.
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Inovio Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Inovio Pharmaceuticals (INO) stock?

A

The latest price target for Inovio Pharmaceuticals (NASDAQ:INO) was reported by Oppenheimer on August 12, 2024. The analyst firm set a price target for $33.00 expecting INO to rise to within 12 months (a possible 381.38% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Inovio Pharmaceuticals (INO)?

A

The latest analyst rating for Inovio Pharmaceuticals (NASDAQ:INO) was provided by Oppenheimer, and Inovio Pharmaceuticals maintained their outperform rating.

Q

When was the last upgrade for Inovio Pharmaceuticals (INO)?

A

The last upgrade for Inovio Pharmaceuticals Inc happened on January 25, 2024 when Oppenheimer raised their price target to $4. Oppenheimer previously had a perform for Inovio Pharmaceuticals Inc.

Q

When was the last downgrade for Inovio Pharmaceuticals (INO)?

A

The last downgrade for Inovio Pharmaceuticals Inc happened on November 9, 2022 when Maxim Group changed their price target from N/A to N/A for Inovio Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Inovio Pharmaceuticals (INO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inovio Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inovio Pharmaceuticals was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Inovio Pharmaceuticals (INO) correct?

A

While ratings are subjective and will change, the latest Inovio Pharmaceuticals (INO) rating was a maintained with a price target of $40.00 to $33.00. The current price Inovio Pharmaceuticals (INO) is trading at is $6.86, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch